Cargando…
Biological therapy as an alternative treatment for cytokine release syndrome in patients with COVID-19()
Autor principal: | Solis Cartas, Urbano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642149/ http://dx.doi.org/10.1016/j.rcreue.2020.06.012 |
Ejemplares similares
-
Terapia biológica como tratamiento alternativo al síndrome de liberación de citocinas en pacientes con COVID-19
por: Solis Cartas, Urbano
Publicado: (2022) -
Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome
por: Faqihi, Fahad, et al.
Publicado: (2020) -
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
por: Hu, Yongxian, et al.
Publicado: (2016) -
Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series
por: Nakamura, Hideta, et al.
Publicado: (2020) -
Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy
por: Zhang, Lina, et al.
Publicado: (2021)